Company Filing History:
2 out of 3 
1 out of 1 
1 out of 833,002 Years Active: 1994-2001
Title: Innovator Jean De Lafonteyne: Pioneering Genetic Manipulations
Introduction: Jean De Lafonteyne is an accomplished inventor based in Oudenaarde, Belgium, known for his innovative contributions in the field of genetic engineering. With a total of three patents to his name, De Lafonteyne has made significant strides in providing solutions for eukaryotic organisms through genetic manipulations.
Latest Patents: De Lafonteyne's most notable inventions involve recombinant DNA technology that incorporates sequences derived from RNA viruses. His patented work aims to protect eukaryotic organisms against RNA viruses and enables inducible or tissue-specific production of foreign proteins, peptides, or RNAs. One of his inventions describes recombinant DNA that comprises two inverted repeat nucleotide sequences, along with at least one nucleotide sequence derived from an RNA virus crucial for replication. Importantly, these sequences do not code for viral RNA or coat proteins, emphasizing their innovative approach to genetic safety and efficacy.
Career Highlights: Throughout his career, De Lafonteyne has been associated with prominent companies such as Aveve N.V., where he further advanced his research in genetic engineering. His work has been pivotal in establishing methods for the genetically incorporated recombinant DNA for the protection of various cell types.
Collaborations: De Lafonteyne has collaborated with notable figures in the field, including Eddie Van Haute and Paul Ameloot, facilitating a fruitful exchange of ideas and expertise. These collaborations have helped cultivate an environment of innovation and creativity in the realm of genetic research.
Conclusion: Jean De Lafonteyne stands out as a trailblazer in the field of genetic manipulations, with his pioneering patents contributing to the understanding and application of recombinant DNA technology. His work not only provides critical advancements in protecting organisms against RNA viruses but also highlights the importance of innovative thinking in the pursuit of scientific progress.